What Pharma Executives Secretly Think About the Future (But Won’t Admit Publicly)
The Medical Futurist
MAY 12, 2025
The technology could even tailer medication doses to individual patients; but only one company, FabRx , has been spearheading this field. For example, the generative AI model developed in collaboration between NVIDIA and Recursion Pharmaceuticals demonstrated its unique screening prowess. It can screen more than 2.8
52 
Let's personalize your content